Racemetyrosine

Racemetyrosine

SCHEMBL61871

CC(N)(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TH

The experimentally established mechanism targets of Racemetyrosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 1.00
ALDH1A1 P00352 3/20 0.67
CYP3A4 P08684 3/20 0.67
KDM4E B2RXH2 2/20 0.67
CYP1A2 P05177 2/20 0.67
POLB P06746 2/20 0.67
MAPT P10636 2/20 0.67
HPGD P15428 2/20 0.67
ALOX15 P16050 2/20 0.67
HSD17B10 Q99714 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
USP2 O75604 1/20 0.67
EGFR P00533 1/20 0.67
FYN P06241 1/20 0.67
GAA P10253 1/20 0.67
APEX1 P27695 1/20 0.67
ADRA1A P35348 1/20 0.67
PTGS2 P35354 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metyrosine SCHEMBL50398 1.00 BLM (1.00) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL5053839 1.00 BLM (1.00) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL162280 1.00 BLM (1.00) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL3020472 0.98 BLM (0.96) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL27799143 0.98 BLM (0.96) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL29435134 0.98 BLM (0.96) BLMALDH1A1CYP3A4KDM4ECYP1A2
Metyrosine SCHEMBL6254539 0.98 BLM (0.96) BLMALDH1A1CYP3A4KDM4ECYP1A2
Racemetyrosine SCHEMBL28095637 0.95 BLM (0.90) BLMALDH1A1CYP3A4KDM4ECYP1A2
SCHEMBL24305563 0.85 BLM (0.73) BLMALDH1A1CYP3A4KDM4ECYP1A2
SCHEMBL6717498 0.85 BLM (0.73) BLMALDH1A1CYP3A4KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2443 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260147136-A1 MODULAR COUPLED WATER-HEAT HYDROLOGICAL MODEL OF DISTRIBUTED COLD REGION SICHUAN UNIVERSITY (CN) 2026-05-28 US claimed
CN-122046861-A SPH landslide dynamic simulation method based on space variation rainfall 福州大学 2026-05-15 CN claimed
CN-122047040-A Regional groundwater recharge simulation method based on rainfall intensity dynamic response mechanism 西安交通大学 2026-05-15 CN claimed
CN-120157771-A Incretin polypeptide analogue and application thereof 北京诺尼瑞生物科技有限责任公司 2025-06-17 CN claimed
CN-114357898-B Slope flow velocity spatial distribution estimation method based on terrain and vegetation characteristics 河海大学 2025-05-16 CN claimed
CN-119919845-A Quick optimization method for holographic video based on clustering algorithm 四川大学 2025-05-02 CN claimed
CN-119441682-B Sea cliff safety and stability prediction method considering rainfall influence 华侨大学 2025-04-29 CN claimed
US-20250129127-A1 Systems for Amplification of AAV Rep and Cap Proteins SHAPE THERAPEUTICS INC. 2025-04-24 US claimed
CN-115169150-B Slope unit yield calculation method considering dead drop regulation effect 中国水利水电科学研究院 2025-04-18 CN claimed
CN-119720853-A Three-dimensional simulation-based power grid water and soil conservation method and system 国网河南省电力公司 2025-03-28 CN claimed
EP-0920307-A2 DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM Roche Diagnostics GmbH (DE) 1999-06-09 EP claimed
WO-1999016375-A1 METHOD OF TREATING THE SYNDROME OF CORONARY HEART DISEASE RISK FACTORS IN HUMANS CLEMENS ANTON H (US) 1999-04-08 WO claimed
WO-1999015345-A1 PROCESS FOR REMOVING RESIDUES FROM A SEMICONDUCTOR SUBSTRATE ARCH SPECIALTY CHEMICALS, INC. (US) 1999-04-01 WO claimed
US-5878750-A ADMINISTERING TO THE PATIENT SUFFERING FROM ONE OR MORE CONDITIONS INCLUDING WITHIN THE CORONARY HEART DISEASE RISK FACTOR SYNDROME A DRUG SELECTED FROM OPIATE ANTAGONIST OR ANTI-OPIOID NEURENDO PHARMA, LLC 1999-03-09 US claimed
WO-1998042723-A9 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS 1999-03-04 WO claimed
WO-1998020835-A2 METHOD OF TREATING HYPERLIPIDEMIA IN HUMANS CLEMENS ANTON H (US) 1998-05-22 WO claimed
US-5727570-A OPIATE ANTAGONIST, METHYL TYROSINE NEURENDO PHARMA, LLC 1998-03-17 US claimed
WO-1998006386-A2 DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM ROCHE DIAGNOSTICS GMBH (DE) 1998-02-19 WO claimed
EP-0036713-B1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS UNIVERSITY OF MIAMI (US) 1984-01-18 EP claimed
US-4230883-A REACTION OF CORRESPONDING AMINO ACID WITH HCL OR HBR IN THE ABSENCE OF A SOLVENT MERCK & CO., INC. (US) 1980-10-28 US claimed